GoodRx (GDRX) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free GDRX Stock Alerts $6.97 +0.31 (+4.65%) (As of 04/23/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media GoodRx Short Interest DataCurrent Short Volume9,690,000 sharesPrevious Short Volume9,720,000 sharesChange Vs. Previous Month-0.31%Dollar Volume Sold Short$75.49 millionShort Interest Ratio / Days to Cover5.7Last Record DateFebruary 29, 2024Outstanding Shares395,000,000 sharesFloat Size76,640,000 sharesShort Percent of Float12.64%Today's Trading Volume1,113,596 sharesAverage Trading Volume1,531,385 sharesToday's Volume Vs. Average73% Short Selling GoodRx ? Sign up to receive the latest short interest report for GoodRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGDRX Short Interest Over TimeGDRX Days to Cover Over TimeGDRX Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. GoodRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20249,690,000 shares $75.49 million -0.3%12.6%5.7 $7.79 2/15/20249,720,000 shares $65.42 million -0.2%12.8%6.3 $6.73 1/31/20249,740,000 shares $58.44 million +1.5%13.1%5.5 $6.00 1/15/20249,600,000 shares $63.74 million +18.1%12.9%5.3 $6.64 12/31/20238,130,000 shares $54.47 million +2.9%10.9%5.2 $6.70 12/15/20237,900,000 shares $50.01 million -11.2%10.6%5.6 $6.33 Get the Latest News and Ratings for GDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter. 11/30/20238,900,000 shares $53.31 million +10.2%12.2%6.6 $5.99 11/15/20238,080,000 shares $42.66 million +11.8%13.5%6.4 $5.28 10/31/20237,230,000 shares $35.64 million -13.3%10.8%5.6 $4.93 10/15/20238,340,000 shares $44.29 million +5.6%11.2%4.8 $5.31 9/30/20237,900,000 shares $44.48 million +1.7%10.6%3.9 $5.63 9/15/20237,770,000 shares $46.62 million +12.0%10.5%3.9 $6.00 8/31/20236,940,000 shares $45.32 million +53.9%9.4%3.5 $6.53 8/15/20234,510,000 shares $33.28 million -13.1%6.1%2.3 $7.38 7/31/20235,190,000 shares $47.96 million +2.6%7.4%2.9 $9.24 7/15/20235,060,000 shares $37.75 million +1.2%7.7%3.9 $7.46 6/30/20235,000,000 shares $27.60 million -4.0%7.6%4.6 $5.52 6/15/20235,210,000 shares $30.11 million +7.2%8.0%4.6 $5.78 5/31/20234,860,000 shares $26.39 million -1.6%7.4%3.4 $5.43 5/15/20234,940,000 shares $25.69 million No Change7.5%3.1 $5.20 10/31/202211,900,000 shares $63.90 million -2.5%N/A3.7 $5.37 10/15/202212,200,000 shares $57.95 million -3.2%N/A3.6 $4.75 9/30/202212,600,000 shares $58.84 million +6.4%18.8%3.8 $4.67 9/15/202211,840,000 shares $77.08 million -12.2%17.6%3.6 $6.51 8/31/202213,490,000 shares $82.29 million -10.3%20.2%4.2 $6.10 8/15/202215,040,000 shares $108.44 million -19.3%22.4%4.8 $7.21 7/31/202218,640,000 shares $116.13 million -0.2%28.9%6.9 $6.23 7/15/202218,670,000 shares $121.92 million +1.4%28.9%8.5 $6.53 6/30/202218,420,000 shares $109.05 million +2.3%28.5%8.4 $5.92 6/15/202218,010,000 shares $112.74 million +26.4%27.9%8.2 $6.26 5/31/202214,250,000 shares $113.57 million +22.0%21.7%6 $7.97 5/15/202211,680,000 shares $103.95 million +11.6%17.8%3.6 $8.90 4/30/202210,470,000 shares $141.87 million -8.0%15.4%3.8 $13.55 4/15/202211,380,000 shares $211.67 million +12.7%16.7%4.3 $18.60 3/31/202210,100,000 shares $195.23 million -8.6%N/A3.7 $19.33 3/15/202211,050,000 shares $166.08 million -30.9%16.5%3.9 $15.03 2/28/202215,980,000 shares $437.85 million +10.6%25.5%6.1 $27.40 2/15/202214,450,000 shares $421.65 million -6.1%23.0%9 $29.18 1/31/202215,390,000 shares $369.51 million -3.1%23.2%9.4 $24.01 1/15/202215,880,000 shares $426.38 million +3.9%N/A0 $26.85SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. GDRX Short Interest - Frequently Asked Questions What is GoodRx's current short interest? Short interest is the volume of GoodRx shares that have been sold short but have not yet been covered or closed out. As of February 29th, traders have sold 9,690,000 shares of GDRX short. 12.64% of GoodRx's shares are currently sold short. Learn More on GoodRx's current short interest. What is a good short interest ratio for GoodRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GDRX shares currently have a short interest ratio of 6.0. Learn More on GoodRx's short interest ratio. Which institutional investors are shorting GoodRx? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of GoodRx: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for GoodRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.64% of GoodRx's floating shares are currently sold short. Is GoodRx's short interest increasing or decreasing? GoodRx saw a drop in short interest during the month of February. As of February 29th, there was short interest totaling 9,690,000 shares, a drop of 0.3% from the previous total of 9,720,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is GoodRx's float size? GoodRx currently has issued a total of 395,000,000 shares. Some of GoodRx's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GoodRx currently has a public float of 76,640,000 shares. How does GoodRx's short interest compare to its competitors? 12.64% of GoodRx's shares are currently sold short. Here is how the short interest of companies compare to GoodRx: Janux Therapeutics, Inc. (11.58%), Neogen Co. (7.71%), PROCEPT BioRobotics Co. (9.58%), Integra LifeSciences Holdings Co. (3.16%), Immunocore Holdings plc (9.49%), Evotec SE (0.02%), Summit Therapeutics Inc. (26.25%), Premier, Inc. (3.73%), Indivior PLC (0.13%), QuidelOrtho Co. (3.36%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short GoodRx stock? Short selling GDRX is an investing strategy that aims to generate trading profit from GoodRx as its price is falling. GDRX shares are trading up $0.31 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GoodRx? A short squeeze for GoodRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GDRX, which in turn drives the price of the stock up even further. How often is GoodRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GDRX, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: Janux Therapeutics Short Squeeze Neogen Short Squeeze PROCEPT BioRobotics Short Squeeze Integra LifeSciences Short Squeeze Immunocore Short Squeeze Evotec Short Squeeze Summit Therapeutics Short Squeeze Premier Short Squeeze Indivior Short Squeeze QuidelOrtho Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GDRX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencySHOCKING Crypto Leak…Crypto 101 MediaYour Money is Not SafeAmerican AlternativeDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals